MedPath

Performance of Two Silicone Hydrogel Toric Contact Lenses

Not Applicable
Completed
Conditions
Vision Correction
Interventions
Device: balafilcon A toric
Device: senofilcon A toric
Registration Number
NCT00638846
Lead Sponsor
Johnson & Johnson Vision Care, Inc.
Brief Summary

Evaluation of the clinical performance of two toric contact lenses in a 2-week, single masked (subject), daily wear, randomized, bilateral, parallel group study.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
276
Inclusion Criteria
  • Be between 18 and 45 years of age.

  • Sign Written Informed Consent (See separate document).

  • Be an existing successful daily wear toric soft contact lens.

  • Require a visual correction in both eyes (monovision or uniocular fitting is NOT allowed).

  • Does not require presbyopic correction (can read J1 @ normal reading distance).

  • Have a sphere requirement in the range -1.00 and -5.00D (-5.25D refractive)

  • Have refractive astigmatism between 0.75D and 2.50D in both eyes.

  • Achieve visual acuity of 20/30 or better in each eye with spherical distance correction.

  • Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having:

    • No amblyopia.
    • No evidence of lid abnormality or infection.
    • No conjunctival abnormality or infection.
    • No clinically significant slit lamp findings (i.e. stromal edema, vascularisation, infiltrates or abnormal opacities).
    • No other active ocular disease.
Exclusion Criteria
  • Requires concurrent ocular medication.
  • Clinically significant (Grade 3 or 4) corneal stromal haze, corneal vascularisation, tarsal abnormalities, bulbar hyperemia, limbal hyperemia, or any other abnormality of the cornea that would contraindicate contact lens wear.
  • Corneal staining Grade 3 in more than one region.
  • Has had refractive surgery. Has had eye injury/surgery within 8 weeks immediately prior to enrolment for this study.
  • Abnormal lacrimal secretions.
  • Pre-existing ocular irritation that would preclude contact lens fitting.
  • Keratoconus or other corneal irregularity.
  • Polymethyl methacrylate (PMMA) or Rigid Gas Permeable (RGP) lens wear in the previous 8 weeks
  • Extended lens wear in last 3 months.
  • Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
  • Diabetic.
  • Infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g., HIV).
  • Pregnancy, lactating or planning a pregnancy at the time of enrolment.
  • Participation in any concurrent clinical trial or in last 60 days.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
balafilcon A toricbalafilcon A toricbalafilcon A, daily wear, toric contact lens worn for two weeks
senofilcon A toricsenofilcon A toricsenofilcon A, daily wear, toric contact lens worn for two weeks
Primary Outcome Measures
NameTimeMethod
Lens Orientation1 minute after insertion

Proportion of eyes with lens orientation within 5 degrees of optimal

Lens Stability10-15 minutes after insertion

Lens stability is measured as the amount of rotation induced from blink after the lens has settled.

Subjective Comfort2 weeks of lens wear

Subjective comfort was derived from a weighted combined score calculated from individual comfort-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response. \>0 = comfortable, \< 0 = uncomfortable. Combined measures from Week 1 and Week 5.

Secondary Outcome Measures
NameTimeMethod
Time to Fit Lensafter lens insertion

Time required for the optometrist to fit the lens.

Subjective Lens Visionmeasured at 1 and 2 weeks

A weighted combined score calculated from individual vision-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response was used to derive vision outcomes. \>0 = satisfactory vision, \< 0 = unsatisfactory vision. Analysis is performed on combined 1 week and 2 week data.

Overall Corneal StainingAfter 2 weeks use

National Eye Institute 0-3 Scale: Grade 0 = Normal, Grade 1 = Mild, superficial stippling, Grade 2 = Moderate, punctuate staining including superficial abrasion of the cornea, Grade 3 = Severe, abrasion or corneal erosion, deep corneal abrasion or recurrent erosion.

Trial Locations

Locations (19)

Matus Eyecare

🇺🇸

Franklin, Wisconsin, United States

Dr. Larry Menning

🇺🇸

Chamberlain, South Dakota, United States

Camp Eye Care Clinic

🇺🇸

North Little Rock, Arkansas, United States

James R. Dugue, O.D.

🇺🇸

Mission Viejo, California, United States

Executive Park Eye Care

🇺🇸

Colorado Springs, Colorado, United States

Dr. Ted Brink and Associates

🇺🇸

Jacksonville, Florida, United States

Grene Vision Group

🇺🇸

Neodesha, Kansas, United States

Advanced Eyecare, PC

🇺🇸

Raytown, Missouri, United States

Dr. James Brobst

🇺🇸

Florence, New Jersey, United States

Fine Eye Care Associates

🇺🇸

Rochester, New York, United States

Selden Eyecare LLC

🇺🇸

Kittanning, Pennsylvania, United States

Warren Ophthalmology Associates

🇺🇸

Warren, Ohio, United States

Dr. David W. Ferris and Associates

🇺🇸

Warwick, Rhode Island, United States

Nittany Eye Associates

🇺🇸

State College, Pennsylvania, United States

Wishnow-Sugar Vision Group

🇺🇸

Katy, Texas, United States

Dr. William Bogus

🇺🇸

Salt Lake City, Utah, United States

Midlothian Optometric Center

🇺🇸

Midlothian, Virginia, United States

The Eye Specialists, Ltd.

🇺🇸

Virginia Beach, Virginia, United States

The Eye & Contact Lens Clinic

🇺🇸

Bremerton, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath